Weight loss medications can reduce the efficacy of oral contraceptives. What to know before taking drugs like Ozempic, Mounjaro ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

This could really move the needle in the GLP-1 weight loss market. Semaglutide, the active ingredient in Ozempic and Wegovy, is injected into the fatty tissue just under the skin of the stomach, thigh ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The pharmaceutical giant Eli Lilly announced last week that its ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.

Needle-less to say, it’s effective! Eli Lilly’s experimental GLP-1 pill caused participants in a late-stage trial to shed an average of 10.5% of their body weight — nearly 23 pounds — over 16 months, ...